Research Article

Immunophenotypic Characterization of Citrate-Containing A Concentrates in Maintenance Hemodialysis: A Pre-Post Study

Table 1

Baseline characteristics of the study population.

ParametersTotal N = 61Unit 1 N = 35Unit 2 N = 26 value

Age (years; mean ± SD)69.9 ± 15.669.6 ± 16.670.2 ± 14.60.90
Gender, male (n%)30 (49.2)19 (54.3)11 (42.3)0.36
BMI (kg/m2, mean ± SD)25.8 ± 4.825.9 ± 5.025.7 ± 4.60.86
Dialysis vintage (months; median, IQR)34 (15.59)38 (17.58)29 (14.61)0.67
Anuric (n%)14 (23.0)5 (14.3)9 (34.6)0.06
Overweight (n%)30 (49.2)16 (45.7)14 (53.8)0.53
CCI4 (2.8)6 (3.8)2.5 (1.7)0.16
Arteriosclerosis (n%)22 (36.1)15 (42.9)7 (26.9)0.20
Coronary heart disease (n%)20 (32.8)13 (37.1)7 (26.9)0.40
Diabetes mellitus (n%)20 (32.8)13 (37.1)7 (26.9)0.40
History of myocardial infarction (n%)11 (18.0)7 (20)4 (15.4)0.65
Central vascular disease (n%)12 (19.7)7 (20)5 (19.2)0.94
Heart failure (n%)5 (8.2)3 (8.6)2 (7.7)0.90
Pulmonary hypertension (n%)7 (11.5)5 (14.3)2 (7.7)0.43
Atrial fibrillation (n%)16 (26.2)10 (28.6)6 (23.1)0.63
COPD (n%)6 (9.8)6 (17.1)0 (0)0.03
Peripheral arterial disease (n%)11 (18)7 (20.0)4 (15.4)0.65
Medication
Immunosuppressive medication (n%)22 (36.1)11 (31.4)11 (42.3)0.39
 Glucocorticoid (GC)7 (11.5)1 (2.9)6 (23.1)
 NSAIDs13 (21.3)9 (25.7)4 (15.4)
 Tacrolimus1 (1.6)1 (2.9)0
 Mycophenolate mofetil1 (1.6)01 (3.8)
 GC + MMF + NSAID1 (1.6)01 (3.8)
Statin (n%)29 (47.5)17 (48.6)12 (46.2)0.85
Blood pressure medication (n%)58 (95.1)33 (94.3)25 (96.2)0.74
Patients required hospitalization due to infectious events within 24 monthsb15 (24.6)12 (34.3)3 (11.5)0.05

Body mass index (BMI); Carlson comorbidity index (CCI); chronic obstructive pulmonary disease (COPD); nonsteroidal anti-inflammatory drugs (NSAIDs). Values are given as either mean ± standard deviation or number (percentage) or median (IQR). The independent-samples t-test and the Wilcoxon–Mann–Whitney U test were used for comparison of dialysis units at baseline.  < 0.05 was considered significant. aOne patient was prescribed combined immunosuppressive treatment. b1 missing value.